Trials / Completed
CompletedNCT02200237
A Clinical Study for Inactivated Vaccine Against EV71
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 366 (actual)
- Sponsor
- Medigen Vaccine Biologics Corp. · Industry
- Sex
- All
- Age
- 2 Months – 12 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate the safety, reactogenicity and immunogenicity of EV71 vaccine in health children and infants aged from 2 months to \<12yrs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | EV71 with adjuvant aluminium phosphate | Two arms, EV71 with aluminium phosphate |
| BIOLOGICAL | Placebo | Phosphate Buffer Saline with adjuvant aluminium phosphate |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-05-01
- Completion
- 2017-08-01
- First posted
- 2014-07-25
- Last updated
- 2017-08-18
Locations
4 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02200237. Inclusion in this directory is not an endorsement.